# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Aug 14, 2023

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2023-08-14
- Accepted by EDGAR: Aug 14, 2023, 11:56 ET
- Period: 2023-08-14
- Accession: 0001104659-23-091130
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000110465923091130/tm2323659d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000110465923091130/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000110465923091130/tm2323659d1_8k.htm

Filed Aug 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-091130. Last ingested by Listed: Nov 15, 2026, 04:18 ET. No prices; not investment advice.
